HXBM Financials Tuesday, July 15, 2014 06:13:24 AM
Post# of 4
Posted On: 07/15/2014 6:13:26 AM
HXBM Financials Tuesday, July 15, 2014 06:13:24 AM
Helix BioMedix, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 1,891 852
Cost of Revenue 733 260
Gross Profit 1,158 591
Operating Expenses
Research and Development 501 749
Sales, General and Admin. 2,355 2,153
Non-Recurring Items 597 532
Other 109 114
Operating Income (2,404) (2,956)
Income From Continuing Operations
Add'l Income/Expense Items 1 (4,016)
Earnings Before Interest and Tax (2,489) (7,037)
Interest Expense - 673
Earnings Before Tax (2,489) (7,711)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary (86) (66)
Net Income Cont. Operations (2,574) (7,776)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (2,489) (7,711)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (2,489) (7,711)
Helix BioMedix, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 1,891 852
Cost of Revenue 733 260
Gross Profit 1,158 591
Operating Expenses
Research and Development 501 749
Sales, General and Admin. 2,355 2,153
Non-Recurring Items 597 532
Other 109 114
Operating Income (2,404) (2,956)
Income From Continuing Operations
Add'l Income/Expense Items 1 (4,016)
Earnings Before Interest and Tax (2,489) (7,037)
Interest Expense - 673
Earnings Before Tax (2,489) (7,711)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary (86) (66)
Net Income Cont. Operations (2,574) (7,776)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (2,489) (7,711)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (2,489) (7,711)
(0)
(0)Helix Biomedix Inc (HXBM) Stock Research Links
Scroll down for more posts ▼